Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria | Science Signaling
Opioid system is necessary but not sufficient for antidepressive actions of ketamine in rodents | PNAS
Opioid system is necessary but not sufficient for antidepressive actions of ketamine in rodents | PNAS
Ketamine Metabolite (2R,6R)-Hydroxynorketamine Interacts with μ and κ Opioid Receptors | ACS Chemical Neuroscience
Frontiers | The Role of the Kappa Opioid System in Comorbid Pain and Psychiatric Disorders: Function and Implications
κ-opioid receptor - Wikipedia
Use of Ketamine in Hospitalized Patients - The Hospitalist
Frontiers | Uncovering the Underlying Mechanisms of Ketamine as a Novel Antidepressant
Ketamine: A tale of two enantiomers - Luke A Jelen, Allan H Young, James M Stone, 2021
Rapid‐acting antidepressant ketamine, its metabolites and other candidates: A historical overview and future perspective - Hashimoto - 2019 - Psychiatry and Clinical Neurosciences - Wiley Online Library
Frontiers | Dynorphin/kappa opioid receptor system regulation on amygdaloid circuitry: Implications for neuropsychiatric disorders
Attenuation of antidepressant and antisuicidal effects of ketamine by opioid receptor antagonism | Molecular Psychiatry
κ-opioid receptor - Wikipedia
Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism | American Journal of Psychiatry
Contribution of the opioid system to depression and to the therapeutic effects of classical antidepressants and ketamine - ScienceDirect
Contribution of the opioid system to depression and to the therapeutic effects of classical antidepressants and ketamine - ScienceDirect
Ketamine Metabolite (2R,6R)-Hydroxynorketamine Interacts with μ and κ Opioid Receptors | ACS Chemical Neuroscience
Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism | American Journal of Psychiatry
Ketamine Metabolite (2R,6R)-Hydroxynorketamine Interacts with μ and κ Opioid Receptors | ACS Chemical Neuroscience
Ketamine: Promising Path or False Prophecy in the Development of Novel Therapeutics for Mood Disorders? | Neuropsychopharmacology
Special K: What the Real Scoop on Abuse and Addiction to Ketamine? - Women's Recovery
